These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 25814440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N, Corrado A, Guazzi P, Zocco D, Lari E, Radano G, Muhhina J, Fondelli C, Gavrilova J, Chiesi A.
    Methods; 2015 Oct 01; 87():46-58. PubMed ID: 26044649
    [Abstract] [Full Text] [Related]

  • 3. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A.
    Prostate; 2016 Jan 01; 76(1):68-79. PubMed ID: 26417675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.
    Clin Transl Oncol; 2017 Jun 01; 19(6):651-657. PubMed ID: 28054319
    [Abstract] [Full Text] [Related]

  • 6. The complete exosome workflow solution: from isolation to characterization of RNA cargo.
    Schageman J, Zeringer E, Li M, Barta T, Lea K, Gu J, Magdaleno S, Setterquist R, Vlassov AV.
    Biomed Res Int; 2013 Jun 01; 2013():253957. PubMed ID: 24205503
    [Abstract] [Full Text] [Related]

  • 7. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP, Kerin MJ, Dwyer RM.
    Int J Cancer; 2016 Oct 01; 139(7):1443-8. PubMed ID: 27170104
    [Abstract] [Full Text] [Related]

  • 8. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, Zöller M.
    Int J Cancer; 2015 Jun 01; 136(11):2616-27. PubMed ID: 25388097
    [Abstract] [Full Text] [Related]

  • 9. Comparison of serum exosome isolation methods for microRNA profiling.
    Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A, Salumets A, Peters M.
    Clin Biochem; 2014 Jan 01; 47(1-2):135-8. PubMed ID: 24183884
    [Abstract] [Full Text] [Related]

  • 10. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY, Li YC, Geng CY, Zhou HX, Gao W, Chen WM.
    Hematol Oncol; 2019 Oct 01; 37(4):409-417. PubMed ID: 31102419
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine.
    Crossland RE, Norden J, Bibby LA, Davis J, Dickinson AM.
    J Immunol Methods; 2016 Feb 01; 429():39-49. PubMed ID: 26723490
    [Abstract] [Full Text] [Related]

  • 12. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
    Lee J, Kwon MH, Kim JA, Rhee WJ.
    Artif Cells Nanomed Biotechnol; 2018 Feb 01; 46(sup3):S52-S63. PubMed ID: 30033809
    [Abstract] [Full Text] [Related]

  • 13. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
    Coon J, Kingsley K, Howard KM.
    Int J Mol Sci; 2020 Jul 27; 21(15):. PubMed ID: 32727045
    [Abstract] [Full Text] [Related]

  • 14. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M, Herrero C, López-Rodrigo O, Castells M, de la Fuente A, Vigués F, Bassas L, Larriba S.
    Int J Mol Sci; 2020 Aug 19; 21(17):. PubMed ID: 32824915
    [Abstract] [Full Text] [Related]

  • 15. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, Bangma CH, Pettersson KS, Jenster G.
    Int J Cancer; 2015 Dec 15; 137(12):2869-78. PubMed ID: 26139298
    [Abstract] [Full Text] [Related]

  • 16. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M, Chacártegui Borrás J, Castiglia M, Van Der Steen N, Mertens I, Pauwels P, Peeters M, Rolfo C.
    J Vis Exp; 2016 May 27; (111):. PubMed ID: 27285610
    [Abstract] [Full Text] [Related]

  • 17. Exosomal miRNAs as biomarkers of recurrent lung cancer.
    Munagala R, Aqil F, Gupta RC.
    Tumour Biol; 2016 Aug 27; 37(8):10703-14. PubMed ID: 26867772
    [Abstract] [Full Text] [Related]

  • 18. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes.
    Gallo A, Tandon M, Alevizos I, Illei GG.
    PLoS One; 2012 Aug 27; 7(3):e30679. PubMed ID: 22427800
    [Abstract] [Full Text] [Related]

  • 19. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M, Sharifi M.
    J Cell Physiol; 2018 Sep 27; 233(9):6370-6380. PubMed ID: 29323722
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
    Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.